| Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection EB Hirsch, VH Tam Journal of Antimicrobial Chemotherapy 65 (6), 1119-1125, 2010 | 741 | 2010 |
| Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes EB Hirsch, VH Tam Expert review of pharmacoeconomics & outcomes research 10 (4), 441-451, 2010 | 607 | 2010 |
| In Vitro Activity of MK-7655, a Novel β-Lactamase Inhibitor, in Combination with Imipenem against Carbapenem-Resistant Gram-Negative Bacteria EB Hirsch, KR Ledesma, KT Chang, MS Schwartz, MR Motyl, VH Tam Antimicrobial agents and chemotherapy 56 (7), 3753-3757, 2012 | 166 | 2012 |
| Ceftolozane/tazobactam and ceftazidime/avibactam: two novel β-lactam/β-lactamase inhibitor combination agents for the treatment of resistant Gram-negative bacterial infections JL Liscio, MV Mahoney, EB Hirsch International journal of antimicrobial agents 46 (3), 266-271, 2015 | 155 | 2015 |
| Clinical management of an increasing threat: outpatient urinary tract infections due to multidrug-resistant uropathogens E Walker, A Lyman, K Gupta, MV Mahoney, GM Snyder, EB Hirsch Clinical Infectious Diseases 63 (7), 960-965, 2016 | 130 | 2016 |
| Randomized comparison of 3 high-level disinfection and sterilization procedures for duodenoscopes GM Snyder, SB Wright, A Smithey, M Mizrahi, M Sheppard, EB Hirsch, ... Gastroenterology 153 (4), 1018-1025, 2017 | 101 | 2017 |
| Activity of fosfomycin and comparison of several susceptibility testing methods against contemporary urine isolates EB Hirsch, BR Raux, PC Zucchi, Y Kim, C McCoy, JE Kirby, SB Wright, ... International journal of antimicrobial agents 46 (6), 642-647, 2015 | 87 | 2015 |
| Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumonia SL Aitken, J Altshuler, DJ Guervil, EB Hirsch, LL Ostrosky-Zeichner, ... International journal of antimicrobial agents 45 (5), 541-544, 2015 | 69 | 2015 |
| Assessment of Antimicrobial Combinations for Klebsiella pneumoniae Carbapenemase–Producing K. pneumoniae EB Hirsch, B Guo, KT Chang, H Cao, KR Ledesma, M Singh, VH Tam The Journal of infectious diseases 207 (5), 786-793, 2013 | 63 | 2013 |
| Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors P Bhagunde, KT Chang, EB Hirsch, KR Ledesma, M Nikolaou, VH Tam Antimicrobial agents and chemotherapy 56 (5), 2237-2240, 2012 | 62 | 2012 |
| Integrated microfluidic platform for rapid antimicrobial susceptibility testing and bacterial growth analysis using bead-based biosensor via fluorescence imaging P Sabhachandani, S Sarkar, PC Zucchi, BA Whitfield, JE Kirby, EB Hirsch, ... Microchimica Acta 184, 4619-4628, 2017 | 52 | 2017 |
| Assessment of fosfomycin for complicated or multidrug-resistant urinary tract infections: patient characteristics and outcomes SE Giancola, MV Mahoney, MD Hogan, BR Raux, C McCoy, EB Hirsch Chemotherapy 62 (2), 100-104, 2017 | 50 | 2017 |
| The activity of antimicrobial surfaces varies by testing protocol utilized MD Campos, PC Zucchi, A Phung, SN Leonard, EB Hirsch PLoS One 11 (8), e0160728, 2016 | 42 | 2016 |
| Susceptibility of multidrug-resistant gram-negative urine isolates to oral antibiotics EB Hirsch, PC Zucchi, A Chen, BR Raux, JE Kirby, C McCoy, ... Antimicrobial agents and chemotherapy 60 (5), 3138-3140, 2016 | 40 | 2016 |
| Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but … CC Walsh, CB Landersdorfer, MP McIntosh, AY Peleg, EB Hirsch, ... Journal of Antimicrobial Chemotherapy 71 (8), 2218-2229, 2016 | 37 | 2016 |
| Volatile metabolic diversity of Klebsiella pneumoniae in nutrient-replete conditions CA Rees, KV Nordick, FA Franchina, AE Lewis, EB Hirsch, JE Hill Metabolomics 13, 1-11, 2017 | 33 | 2017 |
| Ceftolozane-tazobactam and ceftazidime-avibactam activity against β-lactam-resistant Pseudomonas aeruginosa and extended-spectrum β-lactamase-producing Enterobacterales … EB Hirsch, HV Brigman, PC Zucchi, A Chen, JC Anderson, GM Eliopoulos, ... Journal of Global Antimicrobial Resistance 22, 689-694, 2020 | 32 | 2020 |
| Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative Activity K Takrouri, HD Cooper, A Spaulding, P Zucchi, B Koleva, DC Cleary, ... ACS Infectious Diseases 2 (6), 405-426, 2016 | 32 | 2016 |
| Adenosine triphosphate quantification correlates poorly with microbial contamination of duodenoscopes LB Olafsdottir, SB Wright, A Smithey, R Heroux, EB Hirsch, A Chen, ... infection control & hospital epidemiology 38 (6), 678-684, 2017 | 29 | 2017 |
| Critical evaluation of ceftolozane–tazobactam for complicated urinary tract and intra-abdominal infections SE Giancola, MV Mahoney, TE Bias, EB Hirsch Therapeutics and clinical risk management, 787-797, 2016 | 29 | 2016 |
Vincent H. TamUniversity of HoustonPatvirtintas el. paštas uh.edu
